>
BANG! Rachel Maddow just got CLOWNED on live television
Eruption In "BleachBit," "Wipe Hard Drive," "Offshore Bank" Searches I
Federal Judge Sides With D.O.G.E. - Full Access to ALL Electronic Records! Big Win for Trump
STOP IT! The Great Taking Documentary Film
Flying Car vs. eVTOL: Which Is the Best New Kind of Aircraft?
NASA and General Atomics test nuclear fuel for future moon and Mars missions
Iran Inaugurates First-Ever Drone Carrier Warship In Persian Gulf
Fix your dead Lithium RV battery - How to Reset LiFePO4 Battery BMS
New fabric can heat up almost 50 degrees to keep people warm in ultracold weather
Finally! A Battery That's Better Than Energizer and Duracell!
What's better, 120V or 240V? A Kohler generator experiment.
MIT names 10 breakthrough technologies to watch in 2025
Watch China's 4-legged 'Black Panther 2.0' robot run as fast as Usain Bolt
Scientists Just Achieved a Major Milestone in Creating Synthetic Life
After the findings of the study were published, Australian Professor Ian Brighthope has classified the injections as class one carcinogens.
More than a year ago, Professor Dr. Angus Dalgleish, a renowned oncologist practising in the UK, first published his concerns that his patients with melanoma were relapsing after several years of being in remission.
"I could find none of the usual causes but on further investigation, I realised that they had all had a booster covid vaccine between three weeks and three months before their cancer's resurgence, the time in which their immune repression fails," he wrote in The Conservative Woman on Monday.
After raising the alarm that the vaccine boosters could induce cancer relapse, he became aware of literally dozens of people who had not had cancer before developing leukaemia and lymphomas after the boosters.
In November 2022, Prof. Dalgleish wrote an open letter to the editor-in-chief of the medical journal The BMJ, urging the journal that harmful effects of Covid injections be "aired and debated immediately" because cancers and other diseases are rapidly progressing among "boosted" people.
A few weeks later, he reported that other oncologists had contacted him to say they were seeing the same phenomenon of the recurrence of cancer in many melanoma patients who had been stable for long periods.